AGILENT TECHNOLOGIES, INC.
At today's price, AGILENT TECHNOLOGIES, INC. (A) is priced for today's economics sustained for ~11.3 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
- At $127, the price for Agilent's life sciences and diagnostics engine works backward to roughly eight years of operating growth held near the top of its sustainable range. Only the growth-DCF family of methods reaches the price; the asset, earnings-power, and peer-multiple frames all land lower, so the market is paying for durable compounding the static frames cannot see. - The instruments-and-diagnostics business is genuinely high quality: trailing return on equity near 20%, interest coverage
Is A overvalued? See what's priced in →
1,043 institutional managers reported holding A in 13F filings for the quarter ended 2026-03-31. Together they hold about 89% of the company; the top 10 hold 44%. 85 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 5.7M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2.5 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
A has cut its share count 6.9% over the past five years, spending $3.75B on repurchases. It pays a dividend, and has for 14 years running, raised 13 years straight; the current rate is $0.99 a share annually. Cash returned over the past three years: $832.00M in dividends and $2.21B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at A over the trailing three years: 2023: 1 buy totaling $0k. 24 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
A's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-09-01 | -4.2% | -10.6% |
| 2023-12-21 | -0.6% | -5.0% |
| 2024-03-06 | +4.2% | -2.3% |
| 2024-06-04 | -11.3% | +4.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
A's latest 8-K filings: 2026-06-25 (items 1.01, 2.03, 9.01); 2026-05-27 (items 2.02, 5.02, 9.01); 2026-05-04 (items 5.02, 7.01, 9.01); 2026-04-03 (items 5.01, 9.01); 2026-03-20 (items 5.03, 5.07, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.